EP3879996A1 - Method for producing an ingredient comprising a combination of at least three milk proteins, and use of the ingredient obtained - Google Patents
Method for producing an ingredient comprising a combination of at least three milk proteins, and use of the ingredient obtainedInfo
- Publication number
- EP3879996A1 EP3879996A1 EP19829667.5A EP19829667A EP3879996A1 EP 3879996 A1 EP3879996 A1 EP 3879996A1 EP 19829667 A EP19829667 A EP 19829667A EP 3879996 A1 EP3879996 A1 EP 3879996A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- mass
- equal
- serum proteins
- ingredient
- milk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004615 ingredient Substances 0.000 title claims abstract description 80
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 43
- 102000014171 Milk Proteins Human genes 0.000 title claims abstract description 22
- 108010011756 Milk Proteins Proteins 0.000 title claims abstract description 22
- 235000021239 milk protein Nutrition 0.000 title claims abstract description 22
- 239000000203 mixture Substances 0.000 claims abstract description 166
- 108010017384 Blood Proteins Proteins 0.000 claims abstract description 123
- 102000004506 Blood Proteins Human genes 0.000 claims abstract description 123
- 235000013336 milk Nutrition 0.000 claims abstract description 109
- 239000008267 milk Substances 0.000 claims abstract description 109
- 210000004080 milk Anatomy 0.000 claims abstract description 109
- 239000007788 liquid Substances 0.000 claims abstract description 86
- 108010076119 Caseins Proteins 0.000 claims abstract description 78
- 102000011632 Caseins Human genes 0.000 claims abstract description 78
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 72
- 235000021240 caseins Nutrition 0.000 claims abstract description 72
- 229940021722 caseins Drugs 0.000 claims abstract description 62
- 235000013365 dairy product Nutrition 0.000 claims abstract description 59
- 238000000034 method Methods 0.000 claims abstract description 33
- 238000002156 mixing Methods 0.000 claims abstract description 18
- 230000008569 process Effects 0.000 claims abstract description 17
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims abstract description 10
- 235000013351 cheese Nutrition 0.000 claims description 84
- 235000018102 proteins Nutrition 0.000 claims description 80
- 102000004169 proteins and genes Human genes 0.000 claims description 80
- 108090000623 proteins and genes Proteins 0.000 claims description 80
- 239000000843 powder Substances 0.000 claims description 55
- 235000013618 yogurt Nutrition 0.000 claims description 54
- 239000006071 cream Substances 0.000 claims description 38
- 239000012141 concentrate Substances 0.000 claims description 27
- 240000002129 Malva sylvestris Species 0.000 claims description 19
- 235000006770 Malva sylvestris Nutrition 0.000 claims description 19
- 238000009928 pasteurization Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 235000015140 cultured milk Nutrition 0.000 claims description 6
- 210000002966 serum Anatomy 0.000 claims description 6
- 230000015271 coagulation Effects 0.000 claims description 5
- 238000005345 coagulation Methods 0.000 claims description 5
- 239000000499 gel Substances 0.000 claims description 5
- 235000015243 ice cream Nutrition 0.000 claims description 5
- 235000021185 dessert Nutrition 0.000 claims description 4
- 235000012438 extruded product Nutrition 0.000 claims description 4
- 235000021001 fermented dairy product Nutrition 0.000 claims description 4
- 235000008983 soft cheese Nutrition 0.000 claims description 4
- 241000195940 Bryophyta Species 0.000 claims description 3
- 235000011929 mousse Nutrition 0.000 claims description 3
- 235000008924 yoghurt drink Nutrition 0.000 claims description 3
- 238000005507 spraying Methods 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims 1
- 230000000052 comparative effect Effects 0.000 description 32
- 239000000047 product Substances 0.000 description 26
- 238000000265 homogenisation Methods 0.000 description 25
- 238000010438 heat treatment Methods 0.000 description 17
- 238000012360 testing method Methods 0.000 description 17
- 230000001953 sensory effect Effects 0.000 description 14
- 238000003756 stirring Methods 0.000 description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000005862 Whey Substances 0.000 description 11
- 102000007544 Whey Proteins Human genes 0.000 description 11
- 108010046377 Whey Proteins Proteins 0.000 description 11
- 239000005018 casein Substances 0.000 description 10
- 235000013305 food Nutrition 0.000 description 10
- 238000000889 atomisation Methods 0.000 description 9
- 239000011248 coating agent Substances 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 239000007921 spray Substances 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 238000005374 membrane filtration Methods 0.000 description 6
- 239000000693 micelle Substances 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 238000005086 pumping Methods 0.000 description 6
- 235000020183 skimmed milk Nutrition 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 229940108461 rennet Drugs 0.000 description 5
- 108010058314 rennet Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229940088598 enzyme Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001471 micro-filtration Methods 0.000 description 3
- 210000003254 palate Anatomy 0.000 description 3
- 239000008188 pellet Substances 0.000 description 3
- 239000012465 retentate Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- FJMAXCRRCJSCIE-UHFFFAOYSA-N N-acetylglycine-N-methylamide Chemical compound CNC(=O)CNC(C)=O FJMAXCRRCJSCIE-UHFFFAOYSA-N 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 108010067454 caseinomacropeptide Proteins 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 238000011026 diafiltration Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 235000005686 eating Nutrition 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000005417 food ingredient Substances 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 238000007430 reference method Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 101000798100 Bos taurus Lactotransferrin Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 238000007696 Kjeldahl method Methods 0.000 description 1
- 102000004407 Lactalbumin Human genes 0.000 description 1
- 108090000942 Lactalbumin Proteins 0.000 description 1
- 102000010445 Lactoferrin Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 229940072440 bovine lactoferrin Drugs 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 235000020246 buffalo milk Nutrition 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000003508 chemical denaturation Methods 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 235000020979 dietary recommendations Nutrition 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000020250 donkey milk Nutrition 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 235000013341 fat substitute Nutrition 0.000 description 1
- 239000003778 fat substitute Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
- 235000021242 lactoferrin Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000010907 mechanical stirring Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000014059 processed cheese Nutrition 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000020254 sheep milk Nutrition 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000001370 static light scattering Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- -1 thiamin-B1 Natural products 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 235000021241 α-lactalbumin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C19/00—Cheese; Cheese preparations; Making thereof
- A23C19/02—Making cheese curd
- A23C19/05—Treating milk before coagulation; Separating whey from curd
- A23C19/053—Enrichment of milk with whey, whey components, substances recovered from separated whey, isolated or concentrated proteins from milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/202—Casein or caseinates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
- A23J1/205—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
Definitions
- the present invention relates to the manufacture of an ingredient resulting from the transformation of dairy proteins, in particular comprising micellar caseins and milk serum proteins, as well as the use of such an ingredient, in particular in the manufacture of dairy products.
- Nutritional recommendations to fight obesity include eating less fat, less salty, less sweet, reducing food portions, and eating meat among others.
- the destructuring of meals and new eating habits lead consumers to seek healthier products enriched with proteins, such as nutritional snacks.
- dairy products such as for example the creamy one
- texture it is sought after food ingredients which can be added at different stages of the production of the food product.
- serum milk proteins being by-products obtained following the transformation of milk, in particular in the manufacture of cheese, it is sought various means of valuing them.
- Denatured serum proteins are thus known as fat substitutes in fat-reduced food products.
- WO 2017/37345, WO 2007/108709 and WO 97/05784 describe different methods of denaturing milk serum proteins.
- EP 0.696.426 A1 describes the manufacture of a texturing agent to improve the functionalities of dairy products comprising an advanced heat treatment, of a composition comprising a skimmed milk added with serum proteins, in order to cause it to precipitate, followed by application of a pressure of 300-400 bars for its homogenization, and of an atomization still applying a high pressure to obtain a powder.
- the texturing agent comprises less than 25% by mass relative to its dry mass of caseins.
- EP 2,340,052 A1 describes the manufacture of a cheese and not of an ingredient intended to improve the organoleptic properties of a dairy product. Part of the soluble proteins in the initial milk is replaced by denatured serum proteins. The mass proportion of native serum proteins is greater, approximately at least twice, than the mass proportion of denatured serum proteins. The ratio of the dry mass in fat to the total dry mass in the ingredient in cheese is of the order of 42%.
- WO 2015/059248 describes a method for manufacturing low-fat denatured milk serum proteins having a significant amount of soluble caseinomacropeptide (CMP).
- CMP soluble caseinomacropeptide
- This composition of denatured serum proteins would improve the emulsifying properties of food products comprising them without forming a gel and would keep their viscosity low.
- the denatured serum proteins are added in powder to skimmed milk, with other ingredients, also added individually in powder, such as caseinates or serum protein concentrates whose mass fraction in serum proteins varies.
- the present invention relates to a dairy food ingredient intended to improve the functional properties, in particular sensory properties, of food products, in particular dairy products.
- the present invention relates, according to a first aspect, to a method of manufacturing an ingredient comprising the combination of at least three dairy proteins, characterized in that it comprises:
- micellar caseins A1, the milk serum proteins B1 and the denatured milk serum proteins C1 are mixed in liquid form;
- step ii) comprising a step of applying at least 50 bars to the mixture obtained in step i);
- the ratio of the dry mass of micellar Al caseins to the mass of the total nitrogenous matter (MAT) of the ingredient is greater than or equal to 50%; the ratio of the dry mass of milk serum proteins B1 to the mass of the dry extract of the mixture in step i) is greater than or equal to 5%, and less than or equal to 35%; the ratio of the dry mass of denatured milk serum proteins C1 to the mass of the dry extract of the mixture in step i) is greater than or equal to 5% and less than or equal to 45%; the ratio of the dry mass in fatty matter to the total dry mass of said ingredient is between 0.2% and 6%.
- the inventors have surprisingly discovered that the combination by the liquid route of the three proteins A1, B1 and Cl makes it possible to obtain a more homogeneous mixture and creating interactions which are not obtained when these three proteins are mixed with the powder state.
- the rehydrated solutions according to the invention have a quantity of available proteins (i.e. not decanted) very significantly greater than that observed for the mixture of the three proteins in powder form.
- the ingredient according to the present invention also makes it possible to improve the functional properties of food products, for example the creaminess and the coating of a cream cheese, compared to the addition of the three proteins Al, B1 and Cl in the form of a mixture of three powders.
- Step ii) can also comprise, applied to the mixture obtained at the end of step i), a concentration step and a heat treatment step, or a combination of the latter.
- milk is the normal mammary secretion of milking animals obtained from one or more milkings, without adding or subtracting anything, intended for consumption, such as for example liquid milk, or for further processing (for example cheese making).
- milk without indication of the animal species is, according to French law, reserved for cow's milk. All milk from a dairy female other than the cow must be designated by the name "milk” followed by the indication of the animal species from which it comes, for example: goat milk, sheep milk, donkey milk , buffalo milk.
- milk denotes a milk obtained from a milking animal whatever the indication of the animal species.
- milk proteins are defined as dairy products containing a minimum of 50% milk protein calculated according to the dry matter (Nitrogen x 6.38).
- Total nitrogenous matter (MAT) thus includes milk proteins and non-protein nitrogenous matter.
- Milk proteins include caseins and serum proteins. Caseins represent at least 80% by mass of the total mass of milk proteins. Serum proteins represent at least 20% by mass of the total mass of milk proteins (and are soluble at a pH of 4.6).
- Caseins are organic complexes made up of casein proteins in the form of a loose, tangled chain that binds calcium phosphate chemically. These proteins have a low level of secondary organization (in helices a or in sheets b). A distinction is made between the caseins aS1, aS2, b and K present in cow's milk in the proportions 37%; 10%; 35%; and 12% (w / w). These are small proteins whose molecular mass varies between 19 and 25 kDaltons. Caseins are organized into micelles: they are spherical particles formed by the association of different caseins. The organization of a micelle, that is to say the arrangement and distribution of the various constituents as well as their modes of association, are always hypothetical.
- Caseins The uncharged parts of the caseins would form rigid structures maintained by hydrophobic associations and hydrogen bonds.
- the calcium phosphate would act as a cement which would allow the association of caseins in micelle.
- Casein K would be distributed in heterogeneous packets almost exclusively located on the surface of the micelles.
- Casein K is associated with the micelle by its N-terminal hydrophobic part while its C-terminal hydrophilic part forms protuberances of 5 to 10 nm projected in the aqueous phase thus conferring a "hairy" appearance to the micelle.
- Caseins have the property of precipitating at a pH of 4.6 (isoelectric point) or under the action of certain enzymes such as rennet, in the presence of ionized calcium and at a temperature above 15 ° C.
- the milk proteins remaining after isoelectric precipitation of the caseins are serum proteins.
- micellar casein in particular micellar casein A1
- micellar casein A1 is used in the present text to mean any casein obtained from a milk isolate (ie retentate), in particular resulting from the use of one or more method ( s) filtration, in particular membrane filtration, of milk (such as ultrafiltration, microfiltration, diafiltration or a combination thereof), possibly combined with one or more steps of concentration and / or dilution of said micellar casein.
- Micellar casein can be obtained by filtration of milk, in particular by a microfiltration step, in particular membrane filtration, of milk.
- the micellar Al caseins are / is obtained from a retentate from a membrane filtration step of milk (ultrafiltration and / or microfiltration and / or diafiltration).
- the retentate can undergo one or more steps of concentration of casein proteins (for example by evapoconcentration) and / or of dilution of casein proteins.
- the micellar Al caseins are not and / or do not include caseinates (which are denatured caseins).
- micellar Al caseins are native micellar caseins (that is to say which have not undergone enzymatic and / or chemical denaturation, for example by adding acid (s) or enzyme (s) coagulant (s)).
- Whey native micellar caseins (that is to say which have not undergone enzymatic and / or chemical denaturation, for example by adding acid (s) or enzyme (s) coagulant (s)).
- Whey also called serum or whey
- Whey is the liquid part produced by the coagulation of milk.
- whey produced from the acid production of caseins or fresh cheeses (acid whey); and those from the manufacture of caseins using rennet and cooked or semi-cooked pressed cheeses (mild whey).
- Whey is generally sold in powder form.
- the powder can be rehydrated to form a liquid whey composition.
- Liquid whey comprises, in addition to water, at least 70% by mass relative to its total dry mass, lactose, at least 10% by mass relative to its total dry mass (in particular between 10-13%) soluble protein.
- Whey can include vitamins (including thiamin-B1, riboflavin-B2 and pyridoxine-B6), and minerals (mainly calcium).
- the milk serum protein or also called native or non-denatured milk serum protein, in particular the milk serum protein Bl, can be obtained from a liquid cheese serum (by-product of the cheese factory) or can also be obtained by (ultra ) (micro) filtration, in particular membrane filtration, of milk, or rehydration of a powder, for example of a powder of a serum protein concentrate.
- a serum protein concentrate from a cheese dairy, in particular in its liquid form, is a fraction of the whey from which the lactose has been partially removed to increase the dry mass proportion by serum protein at least 25%, preferably at least 30%, by mass of the total mass of the serum protein concentrate.
- the serum proteins mainly consist of the proteins b-lactoglobulins, of ⁇ -lactalbumin. They can also include immunoglobulins, bovine serum albumin, lactoferrin, and enzymes (lipases, proteases, ).
- Serum proteins are important in determining the thermal stability of milk protein concentrates.
- Serum protein can be denatured.
- the denatured, and in particular concentrated, serum protein is preferably obtained after a denaturation step, and optionally an aggregation step, of the serum protein, in particular said native or non-denatured protein or corresponding to the milk serum protein Bl.
- the denatured milk serum protein is obtained by implementing the following steps:
- a composition in particular a liquid composition, comprising milk serum proteins, in particular undenatured, in particular a concentrate of milk serum proteins, in particular undenatured;
- This mechanical treatment can be a particle stage using at least one homogenization head;
- denatured milk serum proteins possibly cooling; e) obtaining denatured milk serum proteins, preferably having a size greater than or equal to 0.1 ⁇ m, more preferably less than or equal to 100 ⁇ m.
- EP 2 124 583 B1 describes an example of a method for denaturing milk serum proteins which makes it possible to obtain C1 proteins suitable for implementing the invention.
- the particle size is preferably determined by static light scattering using a Mastersizer 3000 particle size analyzer (Malvern Instruments Limited, Malvern, UK).
- the device is equipped with a He / Ne type laser, with a power of 4 mW and operates at a wavelength of 632.8 nm.
- the size of the particles detected by this system is between 0.1 to 3500 ⁇ m.
- the heat treatment in step b) comprises the heat treatment at a temperature greater than or equal to 90 ° C. for at least one second, in particular at least one minute, more preferably for at least ten minutes, of the composition. in step a), in particular at a pressure greater than or equal to 4 MPa or 40 bars, in particular less than or equal to 8 MPa or 80 bars.
- the heat treatment is carried out on a tubular exchanger.
- the mechanical treatment in step c) comprises the application of a pressure (in particular exerting a shear) to the composition, obtained at the end of step a) or b), of at least 30 bars or 3 MPa, in particular at least 60 bars or 60 MPa, in particular using at least one, in particular two, homogenization head (s).
- a pressure in particular exerting a shear
- denatured serum proteins are preferably produced by heating a solution of serum proteins, in particular non-denatured or so-called native proteins, while subjecting the solution to significant shearing.
- denatured milk serum proteins are understood to mean any milk serum protein having physical and functional properties different from those of the so-called native milk serum proteins or corresponding to the serum proteins B1, in particular any so-called native milk serum protein heated to more than 60 ° C, preferably at least 80 ° C for at least one second, especially at least one minute, especially for at least five minutes (especially at most one hour).
- the dry mass of a mixture, concentrated or composition, liquid obtained after evaporation of the water until a dry mass is obtained total stable.
- the total dry mass is calculated using ISO standard 6731: January 2011, "Milk, cream, and condensed unsweetened milk - Determination of dry matter (Reference method)”.
- a powdered protein concentrate or the ingredient according to the invention in powder form, has a dry mass, for example according to the standard defined above, comprising at most 6% by mass of water.
- the proteins Al, Bl, and Cl used, and in particular assembled, by the liquid route, can be obtained directly after preparation of the milk, or by rehydration of powders, preferably the proteins Al and / or Bl and / or Cl is / are obtained from a milk isolate (or possibly from a liquid cheese serum in the case of the Bl and / or Cl proteins) obtained without rehydration of a powder.
- the proteins A1, B1 and Cl, and optionally the liquid compositions A, B and C defined below, are in liquid form during mixing for the preparation of the main composition, they can be obtained directly from the filtration processes of milk or be reconstituted from casein or serum proteins called native or denatured powder which are rehydrated.
- the main composition obtained in step i) is obtained by mixing at least two liquid compositions, a first liquid composition comprising the proteins Al and B1, and a second liquid composition comprising the proteins C1.
- the main composition is obtained by rehydrating at least two powders, each powder corresponding to a dairy protein concentrate chosen from: a dairy protein concentrate of micellar caseins Al, a dairy protein concentrate of serum proteins Bl , and a milk protein concentrate of denatured serum proteins Cl, or a mixture of the latter, in a liquid milk protein concentrate chosen from: a milk protein concentrate of micellar caseins Al, a milk protein concentrate of serum proteins Bl, and a protein concentrate milk of denatured serum proteins Cl, or a mixture of these, preferably a milk protein concentrate of micellar Al caseins.
- the powders are chosen so that the main composition comprises at least the proteins Al, Bl and Cl.
- the main composition is obtained by the mixture of three liquid compositions A, B and C defined below.
- the mixing in step i) is carried out by slow mechanical stirring, in particular by a pendulum agitator, in particular at a speed of rotation greater than or equal to 50 rpm and less than or equal to 300 rpm.
- the mixing time is preferably at least 30 minutes and at most 24 hours.
- the mixture (obtained) in step i) has a pH greater than or equal to 6.00, more preferably greater than or equal to 6.70.
- this pH is maintained during step ii).
- the mixture is preferably at a temperature greater than or equal to 2 ° C. and less than or equal to 15 ° C. during step i).
- the mixture and / or the proteins A1, B1 and Cl in liquid form during mixing can thus be cooled to reach this temperature range if necessary.
- the main composition is mixed until a homogenized mixture is obtained.
- step i) can also be carried out online of the liquid compositions A, B and C supplied by means of an automated supply device, the turbulent flow in each of the supply conduits for liquid compositions A , B and C ensures the mixing of compositions A, B and C and obtaining a homogenized mixture.
- the concentration stage during stage ii) comprises the evaporation, in particular under vacuum, in particular by heating at a temperature lower or equal to 80 ° C, in particular lower or equal to 65 ° C, of a fraction of the water contained in the main composition in order to increase its dry extract.
- the evacuation is greater than or equal to 0.03 bars and less than or equal to 0.25 bars. The duration of application of the concentration step depends on the level of dry matter targeted, in particular at least one minute.
- the concentration can be carried out by means of a falling flow evaporator and / or a scraped surface, in particular under a stress of 50 revolutions / min at 45 ° C.
- step ii) is / comprises a step of applying at least 50 bars, preferably at least 100 bars, in particular less than or equal to 500 bars, to the mixture obtained at the end from step i).
- the mixture is subjected to a pressure greater than or equal to 50 bars (5 MPa), in particular greater than or equal to 100 bars, and less than or equal at 500 bars (50 MPa), preferably less than or equal to 300 bars or 400 bars (30 MPa or 40 MPa).
- a pressure greater than or equal to 50 bars (5 MPa), in particular greater than or equal to 100 bars, and less than or equal at 500 bars (50 MPa), preferably less than or equal to 300 bars or 400 bars (30 MPa or 40 MPa).
- the step of applying at least 50 bars carried out during step ii) may comprise, as described below, homogenization of the mixture of l step i) comprising passing over one or more homogenization heads; (then) and / or pumping the mixture from step i) at high pressure, (then) and / or, its atomization comprising passing over one or more spray heads.
- homogenization of the mixture of l step i) comprising passing over one or more homogenization heads; (then) and / or pumping the mixture from step i) at high pressure, (then) and / or, its atomization comprising passing over one or more spray heads.
- the high-pressure pumping of the mixture obtained after step i) applies a pressure greater than or equal to 10 bars, more preferably greater than or equal to 20 bars, preferably greater than or equal to 30 bars, in particular greater than or equal to 50 bars.
- the duration of application of the shear during pumping is simultaneous during the flow of the mixture, in particular of at least one second.
- step (ii) comprises:
- the mixture therefore changes from 1 bar (atmospheric pressure) to the target pressure, then the pressure is lowered to a pressure below the target pressure.
- the pressure application time is at least one second, from preferably at least 15 seconds, preferably at least 30 seconds, more preferably at least one minute. This step makes it possible to homogenize the mixture by shearing it.
- the application of the pressure, and therefore of the shear, on the mixture of step i) by passing over a homogenization head or a spray nozzle or else by high pressure pumping is simultaneous with its flow, the duration application is therefore very short.
- the mixture has a temperature greater than or equal to 5 ° C and less than or equal to 60 ° C during this application step of at least 50 bars.
- This step can be carried out using a high pressure pump pumping the mixture and then passing it through at least one homogenization head applying a determined pressure (for example 50 bars or 100 bars).
- the number of homogenization heads can be 1 or 2.
- the ingredient obtained is then liquid.
- This step can also be carried out using one or more high-pressure spray nozzles also implementing a high-pressure pump, each spray nozzle applying for example at least 100 bars, in particular between 100 bars and 250 bars. .
- This step is equivalent to an atomization step known in the technical field and also allows, under the concomitant application of drying, to obtain an ingredient in powder form.
- the spray nozzle (s) can be combined with the passage over one or more homogenization heads, the homogenization being carried out first.
- step ii) is / comprises a heat treatment step ii), which is a pasteurization step or a step during which the mixture is heated to a temperature greater than or equal to 65 ° C. for at least 5 seconds, in particular less than 5 minutes, preferably at a temperature greater than or equal to 70 ° C, more preferably at a temperature greater than or equal to 80 ° C, optionally at atmospheric pressure or under vacuum and / or under agitation.
- the mixture at the end of step ii), in particular of concentration has a viscosity greater than or equal to 50 cPoises and less than or equal to 500 cPoises.
- the mixture at the end of step ii) has a dry extract by mass greater than or equal to 5% and less than or equal to 40%, more preferably greater than or equal to 10%, preferably greater than or equal to 15%.
- step ii) comprises in this order: optionally a pasteurization step, optionally a concentration step, optionally a pasteurization step, and an application step of at least 50 bars.
- the ingredient obtained is either liquid or in solid form, in particular in powder form.
- the main composition is obtained by mixing at least one liquid composition A comprising the micellar caseins Al, at least one liquid composition B comprising the milk serum proteins Bl, and at least one liquid composition C including denatured dairy serum proteins Cl.
- the liquid composition A comprising the micellar caseins Al has a dry extract by mass greater than or equal to 1%, more preferably greater than or equal to 5%, preferably greater than or equal to 8%.
- the liquid composition A comprising the micellar caseins Al has a dry extract by mass less than or equal to 50%, more preferably less than or equal to 40%, preferably less than or equal to 35%, in particular less than or equal to 20% .
- the ratio of the mass of the MAT to the mass of the dry extract of the liquid composition A is greater than or equal to 70%, more preferably greater than or equal to 80%.
- the ratio of the dry mass in micellar caseins A1 to the mass of the dry extract of the liquid composition A is greater than or equal to 80%, more preferably greater than or equal to 85%.
- the liquid composition A has a pH of between 6.5 and 7.5.
- the liquid composition B comprising the milk serum proteins B1 has a dry extract by mass greater than or equal to 5%, more preferably greater than or equal to 15%, preferably greater than or equal to 20%.
- the liquid composition B comprising the milk serum proteins B1 has a dry extract of less than or equal to 50%, more preferably less than or equal to 40%, preferably less than or equal to 35%, in particular less than or equal to 30%.
- the ratio of the mass of the MAT to the mass of the dry extract of the liquid composition B is greater than or equal to 70%, more preferably still greater than or equal to 80%.
- the ratio of the dry mass of milk serum proteins B1 to the mass of the dry extract of the liquid composition B is greater than or equal to 70%, more preferably less than or equal to 80%.
- the ratio of the dry mass of the fatty substance to the mass of the dry extract of the liquid composition B is greater than or equal to 2%, more preferably still greater than or equal to 3%.
- the liquid composition B has a pH of between 6.0 and 7.5.
- the liquid composition C comprising the denatured dairy serum proteins Cl has a dry extract by mass greater than or equal to 1%, more preferably greater than or equal to 5%.
- the liquid composition C comprising the denatured dairy serum proteins Cl has a dry extract by mass less than or equal to 50%, more preferably less than or equal to 30%, preferably less than or equal to 20%, in particular less than or equal to 15%.
- the ratio of the mass of the total nitrogenous material (MAT) to the mass of the dry extract of the liquid composition C is greater than or equal to 50%, more preferably greater than or equal to 70%.
- the ratio of the dry mass of denatured milk serum proteins Cl to the mass of the dry extract of the liquid composition C is greater than or equal to 65%, more preferably less than or equal to 80%, in particular less than or equal at 75%.
- the ratio of the dry mass of the fatty substance to the mass of the dry extract of the liquid composition C is greater than or equal to 0.5%, more preferably still greater than or equal to 1%.
- the liquid composition C has a pH of between 6.0 and 7.0.
- micellar caseins Al are a concentrate of casein proteins Al
- the milk serum proteins B1 are a concentrate of milk serum proteins Bl
- the denatured milk serum proteins Cl are a concentrate of denatured milk serum proteins Cl.
- the liquid composition A is a concentrate of casein proteins A1
- the liquid composition B is a concentrate of milk serum proteins Bl
- the composition C is a concentrate of denatured milk serum proteins Cl.
- the ratio of the dry mass of micellar Al caseins to the mass of the total nitrogenous matter (MAT) of the ingredient is greater than or equal to 50%.
- the ratio of the dry mass of micellar Al caseins to the mass of the MAT of the ingredient is less than or equal to 85%, more preferably less than or equal to 65%.
- the ratio of the dry mass of milk serum proteins B1 to the mass of the MAT of the ingredient is between 5% and 25%, preferably between 10% and 20%.
- the ratio of the dry mass of milk serum proteins C1 to the mass of the MAT of the ingredient is between 10% and 45%, preferably between 20% and 30%, more preferably between 20% and 25%.
- the ratio of the mass of total nitrogenous material (MAT) to the mass of the dry extract of the ingredient is greater than or equal to 50%, preferably less than or equal to 95%.
- the ratio of the mass of the MAT to the mass of the dry extract in the ingredient is greater than or equal to 80%, preferably less than or equal to 90%.
- the ratio of the dry mass of lactose to the mass of the dry extract in the ingredient is greater than or equal to 0.1%, preferably less than or equal to 30%.
- the ratio of the dry mass of lactose to the mass of the dry extract in the ingredient is greater than or equal to 1%, preferably less than or equal to 10%.
- the ratio of the dry mass in fatty matter to the total dry mass in the ingredient is between 0.2% and 6%, preferably between 2% and 4%.
- the ratio of the mass of the MAT to the mass of the ash in the ingredient is between 10% and 20%, in particular between 10% and 15%.
- said manufacturing process comprises a pasteurization step carried out during step ii).
- the pasteurization step can be carried out before the concentration step and / or before the application step of at least 50 bars.
- the pasteurization step is the heat treatment step.
- said manufacturing process comprises a spraying step for obtaining a powder.
- the atomization techniques consisting in transforming a liquid ingredient into a solid ingredient, in particular in the form of a powder, are well known in the state of the art.
- the liquid composition A or the micellar caseins Al, in liquid form during mixing i), comprise (d) (nent) at least 50% by mass, preferably at least 70% by mass, relative to its dry extract in mass, of micellar Al caseins.
- the liquid composition B or the milk serum proteins Bl, in liquid form when mixing i) comprises (d) (s) at least 50% by mass, preferably at least 70% by mass, relative to its dry extract in mass, of milk serum proteins Bl.
- the liquid composition C or the denatured dairy serum proteins Cl, in liquid form when mixing i), comprises (d) (s) at least 50% by mass, preferably at least 60% by mass, relative with its dry extract in mass, denatured dairy serum proteins Cl.
- the ratio of the dry mass in micellar Al caseins to the dry mass extract of the mixture in step i) is greater than or equal to 50%, preferably less than or equal to 85%, more preferably less than or equal to 70%, preferably less than or equal to 65%.
- the ratio of the dry mass of milk serum proteins Bl to the mass of the dry extract of the mixture in step i) is greater than or equal to 5%, preferably less than or equal to 35%, again preferably less than or equal to 25%, in particular less than or equal to 15%
- the ratio of the dry mass of denatured milk serum proteins C1 to the mass of the dry extract of the mixture in step i) is greater than or equal to 5%, in particular greater than or equal to 10%, more particularly greater than or equal to 15%, preferably less than or equal to 45%, more preferably less than or equal to 40%, more preferably less than or equal to 35%, possibly less than or equal to 25%.
- the dry mass of denatured milk serum proteins C1 is greater, preferably at least 1.5 times, than the dry mass of milk serum proteins B1 in the mixture in step i).
- the subject of the present invention is, according to a second aspect, an ingredient comprising the combination, in particular the assembly, of at least three milk proteins, comprising micellar caseins Al, denatured milk serum proteins Cl, and milk serum proteins Bl , capable of being obtained by implementing the method according to any one of the variant embodiments defined with reference to a first aspect of the invention.
- the object of the present invention is, according to a third aspect, the use of the ingredient, with reference to the second aspect of the invention, or, obtained by the implementation of the method with reference to the first aspect of the invention, for the production of a dairy product chosen from at least one of the following lists: List I, consisting of stirred yogurts, parboiled yogurts, thermized yogurts, drinking yogurts, yoghurt mousse, stirred fermented milks and parboiled, soft cheeses, fresh cheeses, spun cheeses, spreadable cheeses, uncooked pressed cheese, semi-cooked pressed cheese, cooked pressed cheese, and any dairy product obtained by using a process comprising a coagulation step during which the pH is lowered, or a combination thereof, in particular among acidified and / or fermented dairy products; List II consisting of: dairy products not comprising a stage during which the pH is lowered, in particular cast cheese, spreadable fondues, ice creams and dessert creams, or a combination of these ; and in List III consisting of: protein drinks
- the dairy product can be chosen either from list I or II or III.
- the “cream-cheese” or cream cheeses are unripened, spreadable, rindless cheeses obtained from curds or from a base obtained by lactic fermentation, serving as the basis of certain processed cheeses to which we want to give notes fresh aromatics.
- the dry mass content of fat compared to the total mass (including water) is generally between 18% and 30%, and its dry mass content of proteins compared to its total mass (including water) is included between 4.5% and 8%.
- the present invention allows a creamy cheese or cream cheese to be obtained, the dry mass of the fat relative to its total dry mass is less than or equal to 15%, preferably less than or equal to 11% (in particular greater than 0%).
- a subject of the present invention is, according to a fourth aspect, a dairy product chosen from at least one of the following lists: list I constituted by: chosen from: stirred yogurts, parboiled yogurts, thermostated yogurts, yogurts with drink, yoghurt mousse, fermented and brewed fermented milks, soft cheeses, fresh cheeses, spun cheeses, spreadable cheeses, uncooked pressed cheese, semi-cooked pressed cheese, cooked pressed cheese, and all dairy product obtained by the implementation of a process comprising a coagulation step during which the pH is lowered, or a combination of these, in particular among acidified and / or fermented dairy products; List II consisting of: dairy products not comprising a stage during which the pH is lowered, in particular cast cheese, spreadable fondues, ice creams and dessert creams, or a combination of these ; and in List III consisting of: protein drinks, protein gels, protein bars, extruded products, or a combination of these; or a combination of these.
- Said dairy product also comprises an ingredient, obtained by implementing the method according to any one of the variant embodiments with reference to the first aspect of the invention, or with reference to the second aspect of the invention.
- the dairy product is reduced in fat and / or enriched with milk proteins.
- the ratio of the dry mass of the fat to the dry mass extract of said dairy product is less than or equal to 15%.
- the ratio of the dry mass of the ingredient to the total mass (including water) in the dairy product is greater than 0% and less than or equal to 30%, preferably less than or equal to 20%, and possibly less than or equal to 15%.
- FIG. 1 represents the% of supernatant on the ordinate obtained for different protein concentrations in the mixtures tested by the liquid route (ML1, ML2) and by the dry route (MSI, MS2) and different temperature conditions,
- FIG. 2 is a graph representing on the ordinate the mass percentages of proteins found in the fraction by supernatant and in the fraction remaining at the bottom of the pellet of the test tubes of a mixture obtained by the dispersion of a powdered ingredient according to the invention in water (ML1, ML2), on the one hand, and of a mixture obtained by the dispersion of three powders of proteins (MSI, MS2) on the other hand in water.
- Each of the mixtures comprises 10% by mass of proteins relative to its total mass (including water), and is heated to 50 ° C. with stirring for one hour.
- Figure 3 represents the sensory profiles for cream cheese 1 and comparative cream cheese 1 on a scale of 0 to 4 for 5 evaluated criteria: brittle, coating, creamy, firmness, and granular.
- FIG. 4 represents the sensory profiles for feta 1 and comparative feta 1 1 on a scale of 0 to 4.5 (per increase interval of 0.5) for 5 evaluated criteria: brittle, nappant, creamy, firm, and grainy.
- FIG. 5 shows the firmness (g) and viscosity (cP) obtained on the ordinate for a stirred yogurt 1 according to the invention, a comparative stirred yogurt in which only the micellar caseins Al powder were added, and a comparative stirred yogurt in which only the denatured milk serum proteins C1 in powder were added on the abscissa.
- FIG. 6 represents the sensory profiles of a stirred yogurt 1 (invention) and of a comparative stirred yogurt based on Al micellar caseins, on a scale of 0 to 4 (by increase interval of 0.5) for 5 evaluated criteria: the drying, the coating, the creamy, the firmness, and the grainy.
- FIG. 7 represents the sensory profiles of a fresh cheese according to the invention (fresh cheese ML1) and of a comparative fresh cheese based on Al micellar caseins, on a scale of 0 to 5 (per increase interval of 0.5) for 5 evaluated criteria: brittle, coating, creamy, firmness, and grainy.
- a main composition is prepared by mixing a liquid composition A comprising micellar caseins Al (dry extract by mass of 12.5%; pH of 6.8; mass of MAT / total dry mass of 89%; dry mass of micellar caseins / mass MAT 92%, temperature 5 ° C), with a liquid composition B comprising undenatured milk serum proteins B1 (dry extract by mass of 21%; pH of 6.6; mass of MAT / total dry mass of 84%; temperature of 5 ° C), and a liquid composition C comprising denatured dairy serum proteins Cl (dry extract by mass of 7.1%; pH of 6.6; mass of MAT / total dry mass of 84%; temperature of 5 ° C).
- the ratio (by mass) between the liquid compositions A, B and C is: 1.0: 0.1: 0.8
- the mixture obtained is maintained at a temperature of the order of 5 ° C and at a speed of the order of 200 revolutions / min.
- the main composition obtained at the end of the mixing step i) optionally undergoes a -concentration step ii) to adjust the total dry mass during which the composition is heated to 45 ° C. for at least 5 minutes, especially under vacuum.
- the main composition obtained at the end of step i) or ii) then undergoes a step of applying a pressure of at least 50 bars, by passing over at least one homogenization head applying 50 bars to the mixture.
- the homogenization is carried out using a first head applying first 50 bars, then using a second head applying 50 bars, the mixture is thus subjected to 100 bars.
- Homogenization can be carried out by a GEA homogenizers from the Ariete range. The duration of the homogenization is then simultaneous, in particular at least one second.
- the liquid ingredient is then obtained.
- the liquid ingredient then undergoes a spray atomization step in high pressure nozzles (about 200-300 bars).
- the ingredient is found in powder form and then corresponds to the powder ingredient referenced ML1 in the remainder of this text.
- the mass of the MAT of the ingredient ML1 relative to its total dry mass is of the order of 85%
- the mass of the micellar caseins Al relative to the mass of the MAT is of the order of 60%
- the mass of proteins B1 relative to the mass of MAT is of the order of 15%
- the mass of proteins C1 relative to the mass of MAT is of the order of 25%.
- the liquid compositions B and C come from the cheese dairy
- the liquid composition A comes from membrane filtration of the milk.
- the same process and the same recipe are used for the preparation of an ML3 ingredient with the difference that the process comprises a step of applying 50 bars by pumping the mixture from step i) using a pump. high pressure for its supply to an atomization device to undergo a spray atomization step in high pressure nozzle (s) (200 bars at most).
- the different sources of proteins in liquid form are used for the preparation of the main composition (liquid compositions A, B and C): the micellar caseins Al (sold under the brand PROMILK 872 B by INGREDIA), the serum proteins Bl, and the denatured serum proteins Cl were dried independently of each other according to an atomization process known in the prior art.
- the three powders for the dry route are then mixed in accordance with the recipe used for the ingredients ML1 and ML2 for obtaining the comparative ingredients MSI and MS2.
- Rehydration protocol The rehydration of ML1, ML2, MSI and MS2 powders is carried out at a mass concentration of 5% and 10% protein relative to the total mass of the mixture (including water).
- the powder is dispersed in demineralized water previously heated to 50 ° C.
- the powder is then dispersed with stirring via a turbine with the deflocculating paddle, then left stirring in an oven at 50 ° C. for 1 h. or 2h.
- a mass of sample (Me) is centrifuged (5 min at 300 g) entraining the non-solubilized material in the bottom of the pellet (Eppendorf).
- the supernatants (Ms) are weighed and the rehydration rate is determined by calculation according to the following average formula (Ms / Me) * 100, the results of which are given in the form of a graph in FIG. 1 appended.
- the mixtures of powders obtained by the liquid route (ML1, ML2) have significantly improved rehydration rates compared to the mixtures of powders obtained by the dry route (MSI, MS2), that is an improvement in approximately 11% for mixtures with 5% protein by mass, and approximately 22% for mixtures with 10% protein by mass, regardless of the heating time (1 hour or 2 hours) even when combined with a further heating at 92 ° C for 5 min.
- the various heat treatments do not make it possible to improve the rehydration of dry mixes (MSI, MS2).
- the Cream Cheese tested below are obtained by implementing the following process known as techno quark: mix the skimmed milk and the cream in the tank of a carousel at 50 ° C; when the mixture reaches 50 ° C., add the protein powder with stirring (either the mixture of three powders by the dry route (MSI, MS2), or the ingredient according to the invention in powder form (ML1, ML2); leave to hydrate at 50 ° C for 1 hour with gentle agitation; pasteurize the product obtained in a tubular pasteurizer (with preheating to 72 ° C, then a homogenization step at 72 ° C at 100 bars (two homogenization heads, and 50 bars applied per homogenization head); chamber at 92 ° C for 5 minutes; and cool to 32 ° C); introduce the product in a disinfected bucket; add the ferments (10g of ferment, type XT 208, per 100 Kg of product to be treated), and rennet (Chymax + at a rate of 1.4 ml for the OKOKg of
- Cream cheese comprising 8% by mass of protein on the dry extract were formulated according to the different compositions defined below in Table 1 comprising the addition of an ingredient according to the invention ML1 and ML2, and the addition of a powder obtained by the dry route combining three proteins Al, B1 and Cl (MSI, MS2).
- the evaluated product is packaged in a 170 ml plastic tray between 8 ° C and 10 ° C.
- Cream cheese 1 and 2 according to the invention have a firmness of 43% to 47% greater than in comparison cream cheese 1 and 2.
- Tastings were carried out on Cream Cheese 1 and on Comparative Cream Cheese 1 using the following tests: triangular test according to standard NF ISO 4120: 2007 to establish whether products are considered to be different, preference test, and a descriptive analysis via a tasting to establish the sensory profiles reproduced in Figure 3.
- the triangular test covers three anonymous products presented to those responsible for assessing sensory properties. During this test, it is stipulated that two of these three products are identical, and each tester must then identify the different product (forced choice: when the tester sees no difference, he must indicate a random choice). It takes a number of correct answers for the two products to be identified as different.
- the number of testers is 22.
- the minimum number of correct answers necessary to conclude that there is a perceptible difference is 12 people.
- Cream cheese 1 was thus considered by 19 testers to have more fondant, creamy, being smooth and coating unlike comparative cream cheese 1 considered to be too firm with a spoon, and sandy.
- a tasting is also carried out according to ISO Standard 22935: 2009. Five criteria to be analyzed are determined (Brittle, Grainy, Creamy, Nappant, Firmness), and a panel of 22 tasters is invited to taste the cream cheese 1 and the cream comparative cheese 1.
- Cream cheese 1 has more creamy and thicker than comparative cream cheese 1, and less grainy, firm and brittle than comparative cream cheese 1.
- the ingredient according to the invention makes it possible to significantly improve the sensory properties and the texture of the cream cheese.
- the ingredient according to the present invention thus makes it possible to develop cream cheese low in fat (11% of fat in this example) and having improved taste and nutritional characteristics.
- Feta is a white cheese in milk brine from the Balkans and Turkey, European PDO since 2002.
- the feta generally comprises 23% of fat by mass relative to its total mass and the lightened feta generally comprises between 9 and 10% by mass of fat compared to its total mass.
- the feta produced below comprises 10% fat by mass relative to its total mass.
- the fêtas were made by implementing the following process: mixing and heating the skim milk and the cream to 50 ° C; hydrate the powder ML2 or MS2 or the micellar caseins Al or the denatured dairy serum proteins Cl by adding them to the above mixture of milk and cream at 50 ° C for one hour, without shaking; heating the above mixture to 70 ° C; homogenize at 70 ° C using two homogenization heads, the first head applying 150 bars and the second head applying 50 bars; heat treatment for 15 seconds at 80 ° C; cool the mixture to 40 ° C; add salt with stirring to the mixture; add the ferments with stirring to the mixture (white dairy 80, lU / Kg of feta); add the rennet with stirring (Chymax +, 14 ml pure / 100 Kg of the mixture) for approximately 30 minutes; oven for 16 hours at 32 ° C.
- the pH of the feta obtained is 4.6 to 4.8.
- the feta is stored at 4 ° C, and the analyzes, including tasting tests,
- Table 4 A comparative feta 1 was manufactured according to the same process, and the same composition as that described in Table 4, as those used for the manufacture of feta 1 according to the invention by using the powder MS2, the manufacture of which is described in I) a).
- a triangular test such as that described in paragraph II above, is carried out on feta 1 according to the invention and comparative feta 1.
- the number of testers is 16.
- the number minimum of correct answers necessary to conclude that there is a perceptible difference between feta 1 and comparative feta 1 is 9 people.
- Feta 1 and Comparative Feta 1 are therefore considered to be different.
- the preference test indicates that feta 1 is preferred by 15 tasters over a single taster for comparative feta 1.
- yoghurts and fermented milks must contain a minimum of 2.7% of proteins calculated by multiplying nitrogen by a factor of 6.38. They usually contain 4%.
- a fourth type of stirred yogurt was manufactured, the latter is identical to that obtained with the ingredient ML1, with the difference that the ingredient ML1 is replaced by the ingredient ML3.
- the stirred yogurts were made by implementing the following process: the skimmed milk is mixed in the tank of a carousel at 50 ° C when the mixture reaches 50 ° C, the powder: ML1 or the micellar caseins Al alone or denatured dairy serum proteins Cl, is added with stirring; leave to hydrate at 50 ° C for 45 minutes with gentle stirring; pass the mixture to the tubular pasteurizer (vapor pressure: 1.8 bars; back pressure: 3 bars; preheating to 70 ° C, homogenization at 70 ° C with a first homogenization head applying 50 bars then a second homogenization head at 100 bars, the booster pressure is 3.5 bars, chambering at 92 ° C for 5 min, and cooling to 48 ° C); place the mixture in a disinfected bucket; add the ferments (YF-L812, 50U / 250L of mixture) then mix; incubate at 43 ° C for approximately 6 hours; stop the incubation when the pH reaches 4.65 (+/- 0.05); break the curd
- the viscosity (cP) of the yoghurts is measured using the Haake Viscotester VT7 viscometer (Thermo Scientific, USA) with an R6 geometry, at a shear speed of 100 rpm. The measurement is made by plunging the geometry to the limit indicated by the material ( ⁇ l / 3 of the height of the product). The measurement is carried out on 3 different samples from the same production.
- the texture measurement of the product is carried out using the texturometer TA.XTpIusC, (Stable Micro Systems, UK) as defined in paragraph II with the difference that the geometry used is an extrusion disc referenced A / BE - d35, at a product penetration speed of lmm / s, over a distance of 30mm and an extraction speed of lmm / s.
- the compositions and results of the tests carried out on stirred yogurt 1 as well as the comparative yogurts obtained with either micellar Al caseins added alone, or either denatured serum proteins C1 are given in table 5 below.
- the viscosity and firmness measurements are shown in FIG. 5. From the texture measurements indicated in FIG. 5, it is observed that the comparative stirred yogurts based on denatured C1 serum proteins are not sufficiently textured. This comparative yogurt is described as aqueous in the mouth.
- the stirred yogurt 1 according to the invention offers a firmness (in g) and a viscosity (cP) close to those obtained for the comparative yogurt based on Al micellar caseins alone.
- the yogurt obtained with the ingredient ML3 has a texture of 1 180 g.
- a comparative stirred yogurt 1 was manufactured according to the same process, and the same composition as that described in Table 5, than those used for the manufacture of stirred yogurt 1 according to the invention by using the powder MS2, the manufacture of which is described. to I.
- a triangular test such as that described in paragraph II above, is carried out on the stirred yogurt 1 according to the invention and a comparative stirred yogurt 1.
- the number of testers is 19.
- the minimum number of correct answers necessary to conclude that there is a perceptible difference between stirred yogurt 1 and comparative stirred yogurt 1 is 11 people. We thus obtain, 14 correct answers, 5 wrong answers out of 19 answers.
- the stirred yogurt 1 and the comparative stirred yogurt 1 are therefore deemed to be different.
- the fresh cheeses were produced by implementing the following process: the skimmed milk (i.e. 94.90% by mass of the composition) is mixed in the tank of a carousel at 50 ° C, when the mixture reaches 50 ° C, the powder ML1 or the powder Al (concentrated micellar caseins) (ie 5.10% by mass of the composition) are added with stirring; allowed to hydrate at 50 ° C for 45 minutes with gentle stirring; then the mixture is passed to a plate pasteurizer (92 ° C / 5 min); it is preheated to 70 ° C, homogenized at 70 ° C with a first homogenization head applying 50 bars then a second homogenization head at 100 bars, chambering at 92 ° C for 5 minutes and cooling to 32 ° C; place the mixture in a disinfected bucket; add the ferments (Creamy 1.0, 10U / 100Kg) and the rennet (Chymax + 1.4 ml / 100Kg) then mix; incubate at
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Microbiology (AREA)
- Dairy Products (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1860501A FR3088174B1 (en) | 2018-11-14 | 2018-11-14 | PROCESS FOR MANUFACTURING AN INGREDIENT INCLUDING THE COMBINATION OF AT LEAST THREE MILK PROTEINS, AND USE OF THE INGREDIENT OBTAINED |
PCT/FR2019/052705 WO2020099792A1 (en) | 2018-11-14 | 2019-11-14 | Method for producing an ingredient comprising a combination of at least three milk proteins, and use of the ingredient obtained |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3879996A1 true EP3879996A1 (en) | 2021-09-22 |
Family
ID=65861412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19829667.5A Pending EP3879996A1 (en) | 2018-11-14 | 2019-11-14 | Method for producing an ingredient comprising a combination of at least three milk proteins, and use of the ingredient obtained |
Country Status (5)
Country | Link |
---|---|
US (1) | US20210392919A1 (en) |
EP (1) | EP3879996A1 (en) |
AU (1) | AU2019380695A1 (en) |
FR (1) | FR3088174B1 (en) |
WO (1) | WO2020099792A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3097408B1 (en) * | 2019-06-24 | 2022-06-17 | Inst Nat De La Rech Agronomique Inra | Cheese powder, processes for producing this cheese powder and a cheese foodstuff from the latter |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2340052A1 (en) * | 1976-02-04 | 1977-09-02 | Nestle Sa Soc Ass Tech Prod | CHEESE MAKING PROCESS |
EP0696426A1 (en) * | 1994-08-13 | 1996-02-14 | Societe Des Produits Nestle S.A. | Process for preparing a texture forming agent for milk products |
EP0782825B1 (en) | 1995-08-08 | 2002-11-27 | Snow Brand Milk Products Co., Ltd. | Modified whey protein and process for producing the same |
US20090087538A1 (en) | 2006-03-23 | 2009-04-02 | Palatasa Havea | Dairy Product and Process |
SE530577C2 (en) | 2006-11-22 | 2008-07-08 | Tetra Laval Holdings & Finance | Method for treating a whey protein concentrate by microparticulation |
WO2010026416A1 (en) | 2008-09-04 | 2010-03-11 | Bae Systems Plc | Sterilizing flammable materials by uv irradiation |
WO2015059248A1 (en) | 2013-10-23 | 2015-04-30 | Arla Foods Amba | High protein denatured whey protein composition, related products, method of production and uses thereof |
US10709146B2 (en) * | 2013-10-23 | 2020-07-14 | Arla Foods Amba | CMP-containing, high protein denatured whey protein compositions, products containing them, and uses thereof |
FI127870B (en) | 2015-08-31 | 2019-04-15 | Valio Oy | Microparticulated ideal whey protein preparation, process for its preparation and its use |
-
2018
- 2018-11-14 FR FR1860501A patent/FR3088174B1/en active Active
-
2019
- 2019-11-14 WO PCT/FR2019/052705 patent/WO2020099792A1/en active Application Filing
- 2019-11-14 AU AU2019380695A patent/AU2019380695A1/en active Pending
- 2019-11-14 US US17/292,773 patent/US20210392919A1/en active Pending
- 2019-11-14 EP EP19829667.5A patent/EP3879996A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
FR3088174A1 (en) | 2020-05-15 |
WO2020099792A1 (en) | 2020-05-22 |
US20210392919A1 (en) | 2021-12-23 |
AU2019380695A1 (en) | 2021-06-03 |
FR3088174B1 (en) | 2021-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2428943C (en) | Dairy products with reduced average particle size | |
EP0709034B1 (en) | Process for preparing a texture forming agent for milk products | |
EP3133933B1 (en) | Assembly of at least one plant protein and at least one milk protein, production thereof and uses of same | |
US9775366B2 (en) | Process for producing cream cheese | |
EP1968398B1 (en) | Microfoamed fruit or vegetable puree and method for preparing same | |
CN103796521B (en) | Product and preparation method thereof | |
EP0828432B1 (en) | Process for preparing fresh cheese and fresh cheese obtainable thereby | |
CN115103596A (en) | High protein sour milk product and its production method | |
JP2007195553A (en) | Fat-reduced flavor component | |
EP3879996A1 (en) | Method for producing an ingredient comprising a combination of at least three milk proteins, and use of the ingredient obtained | |
Hill et al. | Dairy ingredients in processed cheese and cheese spread | |
WO1995018539A9 (en) | Method for making melted cheese products, and resulting products | |
FR2714795A1 (en) | Process for producing processed cheese products and products obtained | |
Yadav et al. | Quark cheese: Characteristics, preparation, and recent advances as a functional food | |
EP1947956B1 (en) | Microfoamed fresh dairy product and method for making same | |
WO2022090175A1 (en) | Method for producing a solid ingredient, solid ingredient which can be obtained by implementing said production method, and uses of said ingredient | |
EP0394273A1 (en) | Acid proteinic concentrate obtained from milk, process for its production and its use in cheese making | |
WO2021229021A1 (en) | Composition of fermented fromage frais with a high protein content | |
GB2554905A (en) | Method for the manufacture of a cream cheese | |
Goddik | Fresh Cheese | |
EP2790519A1 (en) | Composition for preparing yogurt from milk, in particular 0% yogurt, and sachet containing such a composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: UNKNOWN |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210511 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: SNAPPE, JEAN-JACQUES Inventor name: LEROUX, RODOLPHE Inventor name: GOURDIN, PIERRE Inventor name: DERENSY, ANTOINE |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230528 |